Zydus Life's plans for cancer biosimilar hit a legal hurdle

The Delhi High Court has granted an interim injunction against Zydus Lifesciences, an Ahmedabad-based drug maker, following a patent infringement case filed by Bristol Myers Squibb concerning its anticancer drug Opdyta (nivolumab).

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Q40EjHC
via IFTTT